Introduction of P2RY2
P2RY2 is encoded by the P2RY2 gene. It belongs to the G-protein-coupled receptor (GPCR) family which is an important drug target and approximately 34% of all FDA approved drugs targeting this family. It is one of the eight subtypes of P2Y receptors (P2RY1, P2RY2, P2RY4, P2RY6, P2RY11, P2RY12, P2RY13 and P2RY14). P2RY2 possesses seven transmembrane alpha helices and is activated by extracellular nucleotides. Meanwhile, P2RY2 is also known as ATP receptor, P2U purinoceptor 1, P2U receptor 1 and purinergic receptor.
|Basic Information of P2RY2|
|Protein Name||P2Y purinoceptor 2|
|Aliases||ATP receptor, P2U purinoceptor 1, P2U receptor 1, Purinergic receptor|
|Organism||Homo sapiens (Human)|
Function of P2RY2 Membrane Protein
The activity of P2RY2 is activated by ATP and UTP, which are the natural agonists for P2RY2. After the activation of P2RY2, like other typical G protein receptor, the intracellular C-terminal of P2RY2 coupled with the G-protein resulting in the phosphorylation of the intracellular C-terminal of P2RY2 and a variety of physiological responses. P2RY2 plays an important role in initiating early inflammatory responses and mediating later regenerative responses required for wound healing, cell migration, and liver regeneration. Since P2RY2 is widely expressed in multiple tissues of our whole body and plays pathophysiological roles in various functionalities, such as lung diseases, cancer progression, and immune diseases. It is a potential therapeutic target of dry eye disease. Diquafosol tetrasodium, which is a pharmaceutical drug for the treatment of dry eye disease, is the first P2RY2 agonists. Currently, numerous agonists targeting P2RY2 are undergoing development to treat different diseases.
Fig.1 Proposed mechanisms of P2RY2. (Khalafalla, 2017)
Application of P2RY2 Membrane Protein in Literature
This article reports the proposed structure and functions of the P2Y2 receptor and summarizes the structure-activity relationship of some more efficient agonists, which are in undergoing development stage, targeting P2Y2 receptor.
This article reviews the recent advances in the understanding of the dry eye disease and reveals the importance of P2Y2 receptor in the treatment of dry eye disease.
Authors in this group apply interleukin-14α-transgenic mice to investigate the role of P2RY2 in autoimmune endocrinopathy. The results of this study suggest that P2Y2 receptor regulates numerous inflammatory responses because it is unregulated during salivary gland inflammation.
This article focuses on the synthesis and development of the new non-nucleotide human P2Y2 receptor antagonists. The authors apply the NanoBRET-based fluorescent assay to evaluate the affinities of the new series of antagonists with astrocytoma cells expressing untagged hP2Y2R.
This article investigates the role of P2Y2 receptor in acute inflammation mice models. The authors of this article show that P2Y2 receptor is important in mediating acute inflammation because P2Y2 receptor deficiency results in the decreased inflammation.
P2RY2 Preparation Options
To obtain the soluble and functional target protein, the versatile Magic™ membrane protein production platform in Creative Biolabs enables many flexible options, from which you can always find a better match for your particular project. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-P2RY2 antibody development services.
Creative Biolabs is a leading global biologics services provider that offers comprehensive, integrated and highly customizable services in the field of membrane protein. Our services are designed to help our worldwide clients shorten the research time and lower the cost of many functional membrane proteins. Please feel free to contact us for more information.